The European Medicines Agency’s EMA’s human medicines committee (CHMP) recommended seven novel medicines for approval at its ...
Between the US government shutdown, crippling international tariffs, debilitating funding cuts to critical research, and the general policy whiplash in Washington DC, it's little wonder many US-based ...
US pharma major Bristol Myers Squibb—in collaboration with Johnson & Johnson—has announced the decision to stop the Phase III ...
TandemAI has announced that it has secured a $22 million Series A extension to further develop its drug discovery platform, ...
The race to find a new treatment for hair loss hotted up last month with two mega funding rounds for Pelage Pharmaceuticals and Veradermics. The deals also demonstrated biopharma’s growing interest in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback